Abbott Laboratories (ABT) Stock Statistics & Valuation Metrics

Abbott Laboratories has a market cap or net worth of CHF148.82B. The enterprise value is CHF201.41B.

Abbott Laboratories has 1,738,872,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Abbott Laboratories’s return on equity (ROE) is 0.28 and return on invested capital (ROIC) is 9.89%.

The current PE Ratio of Abbott Laboratories is 27.8. Abbott Laboratories’s PEG ratio is 0.11.

In the last 12 months, Abbott Laboratories had revenue of 41.95B and earned 13.40B in profits. Earnings per share was 7.67.

In the last 12 months, operating cash flow was 9.12B and capital expenditures -2.20B, giving a free cash flow of 6.92B billion.

Abbott Laboratories pays an annual dividend of CHF0.47, resulting in a dividend yield of 1.99%

Abbott Laboratories upcoming earnings date is Apr 22, 2026, Before Open (Confirmed).

Abbott Laboratories as a current ratio of 1.67, with Debt / Equity ratio of 25.40%

In the past 12 months, Abbott Laboratories has paid -6.39B in taxes.

Abbott Laboratories EV to EBITDA ratio is 18.79, with an EV/FCF ratio of 32.05.

Abbott Laboratories has CHF7.73B in cash and marketable securities with CHF12.94B in debt, giving a net cash position of -CHF5.21B billion.

Gross margin is 55.51%, with operating margin of 16.27%, and net profit margin of 31.95%.

The average price target for Abbott Laboratories is CHF106.81, which is 11.43% higher than the current price. The consensus rating is Strong Buy